The Northern California Chapter of ACS would like to thank the following exhibitors for their support of the NCCACS 2025 Annual Meeting. Be sure to visit each of them onsite in San Francisco!
Aroa Surgery was founded in 2008, and is headquartered in Auckland, New Zealand. Aroa Biosurgery is a soft-tissue regeneration company developing, manufacturing, and distributing medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Aroa Biosurgery's products are based on the regenerative properties of ruminant forestomach extracellular matrix (ECM) technology.
BD – Becton Dickinson and Company is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers.
Founded by world-renowned medical imaging scientists from the University of Chicago, Clarix Imaging’s mission is to empower clinicians with clear tumor visualization and intelligent analysis for precision and personalized medicine based on breakthrough innovations in imaging science and AI. Our first product is the FDA cleared true 3D VSI-360™, which offers surgeons and radiologists unprecedented clarity for intraoperative specimen margin visualization.
At Ethicon, a Johnson & Johnson MedTech company… In collaboration with clinicians and healthcare experts around the world, we develop innovative surgical technologies and solutions to help address some of the most pressing health challenges of our time, such as metabolic disease, cardiovascular disease and cancer.
KLS Martin, a surgical innovator, focuses on improving patient care with a wide range of thoracic surgery solutions. Our thoracic surgery portfolio includes specialized implants for sternal closure, rib fracture stabilization, chest wall reconstruction, and IPS "Individual Patient Solutions" for pre-surgical thoracic planning.
Medtronic’s mission is to contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life.
Octapharma USA, Inc. is a subsidiary for Octapharma AG, a global human protein products powerhouse dedicated to the research and manufacture of human proteins. Patients are treated with Octapharma products in the therapeutic areas of hematology, immunology, and critical care.
PolyNovo is a disruptive medical device company focused on Advanced Wound Care, developing dermal regeneration solutions (NovoSorb® BTM, NovoSorb® MTX) with patented NovoSorb biodegradable polymer technology.
SpecialtyCareis your fully invested and integrated partner – leveraging our network of expert clinicians to tailor solutions for your OR and beyond. SpecialtyCare is the market leader in perfusion, ECMO, intraoperative neuromonitoring, EEG, autotransfusion, sterile processing solutions, and surgical assist. Doctors and hospitals should always have the best possible means to ensure the most positive patient outcomes, while simultaneously maintaining their own financial health and success.
Don’t miss “Autotransfusion: Improving Patient Outcomes and Dispelling Common Myths”, on Saturday, March 14 at 7am in the Ballroom hosted by SpecialtyCare. This is a non-CME activity and is not endorsed by NCCACS.
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care.
Teleflex is the home of Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®.
The Permanente Medical Group (TPMG)is the largest medical group in the United States—and one of the most distinguished. Our 9,500 physicians and 40,000 nurses and staff are leading the transformation of health care. Through nation-leading quality, preeminent research, and superior technology systems, we are delivering superior clinical outcomes and having a positive and often life-changing impact on the health of our 4.4 million patients in Northern California.
